SG11201401289YA - Medicinal agent responsive to metal salen complex compound, and system for controlling in vivo behavior of metal salen complex compound - Google Patents
Medicinal agent responsive to metal salen complex compound, and system for controlling in vivo behavior of metal salen complex compoundInfo
- Publication number
- SG11201401289YA SG11201401289YA SG11201401289YA SG11201401289YA SG11201401289YA SG 11201401289Y A SG11201401289Y A SG 11201401289YA SG 11201401289Y A SG11201401289Y A SG 11201401289YA SG 11201401289Y A SG11201401289Y A SG 11201401289YA SG 11201401289Y A SG11201401289Y A SG 11201401289YA
- Authority
- SG
- Singapore
- Prior art keywords
- complex compound
- salen complex
- metal salen
- controlling
- medicinal agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011220449 | 2011-10-04 | ||
| PCT/JP2012/073900 WO2013051389A1 (en) | 2011-10-04 | 2012-09-19 | Medicinal agent responsive to metal salen complex compound, and system for controlling in vivo behavior of metal salen complex compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201401289YA true SG11201401289YA (en) | 2014-07-30 |
Family
ID=48043553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201401289YA SG11201401289YA (en) | 2011-10-04 | 2012-09-19 | Medicinal agent responsive to metal salen complex compound, and system for controlling in vivo behavior of metal salen complex compound |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9468621B2 (en) |
| EP (1) | EP2764873B1 (en) |
| JP (1) | JP6155190B2 (en) |
| CN (1) | CN104010660A (en) |
| IN (1) | IN2014DN03220A (en) |
| RU (1) | RU2595840C2 (en) |
| SG (1) | SG11201401289YA (en) |
| WO (1) | WO2013051389A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111615557A (en) | 2017-11-22 | 2020-09-01 | 国立大学法人神户大学 | Stable genome editing complex with few side effects and nucleic acid encoding same |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5403834A (en) * | 1992-12-07 | 1995-04-04 | Eukarion, Inc. | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| US5549915A (en) | 1993-01-29 | 1996-08-27 | Magnetic Delivered Therapeutics, Inc. | Magnetically responsive composition for carrying biologically active substances and methods of production |
| EP2036550A4 (en) | 2006-06-28 | 2009-07-15 | Ihi Corp | Drug, drug induction device, magnetic detector and method of designing drug |
| JP5170403B2 (en) * | 2008-03-14 | 2013-03-27 | 国立大学法人 筑波大学 | Compounds that control bacterial growth and applications thereof |
| JP5678662B2 (en) | 2008-11-18 | 2015-03-04 | 日本電気株式会社 | Boiling cooler |
| WO2010058280A1 (en) * | 2008-11-20 | 2010-05-27 | 株式会社Ihi | Auto magnetic metal salen complex compound |
-
2012
- 2012-09-19 CN CN201280049082.8A patent/CN104010660A/en active Pending
- 2012-09-19 EP EP12838216.5A patent/EP2764873B1/en active Active
- 2012-09-19 US US14/349,112 patent/US9468621B2/en active Active
- 2012-09-19 RU RU2014117713/15A patent/RU2595840C2/en active
- 2012-09-19 WO PCT/JP2012/073900 patent/WO2013051389A1/en active Application Filing
- 2012-09-19 SG SG11201401289YA patent/SG11201401289YA/en unknown
- 2012-09-19 JP JP2013537462A patent/JP6155190B2/en active Active
-
2014
- 2014-04-22 IN IN3220DEN2014 patent/IN2014DN03220A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2764873A4 (en) | 2015-04-22 |
| US9468621B2 (en) | 2016-10-18 |
| EP2764873A1 (en) | 2014-08-13 |
| RU2595840C2 (en) | 2016-08-27 |
| JPWO2013051389A1 (en) | 2015-03-30 |
| IN2014DN03220A (en) | 2015-06-26 |
| JP6155190B2 (en) | 2017-06-28 |
| US20140235684A1 (en) | 2014-08-21 |
| RU2014117713A (en) | 2015-11-10 |
| CN104010660A (en) | 2014-08-27 |
| EP2764873B1 (en) | 2018-04-25 |
| WO2013051389A1 (en) | 2013-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE038664T2 (en) | C6-c18-acylated derivative of hyaluronic acid, method of preparation thereof, nanomicellar composition on its basis, method of preparation thereof and method of preparation stabilized nanomicellar composition, and use thereof | |
| EP2538920A4 (en) | Emollient foams for treatment of dermatoses | |
| PL2882779T3 (en) | Hyaluronic acid derivative, method of preparation thereof, method of modification thereof and use thereof | |
| IL250370A0 (en) | 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals | |
| EP2765996A4 (en) | Nanoparticles for controlling bleeding and drug delivery | |
| GB201200718D0 (en) | Improved pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof | |
| EP2664378A4 (en) | Metal structure catalyst and preparation method thereof | |
| IL249826A0 (en) | Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals | |
| HK1218709A1 (en) | New salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof | |
| GB2508200B (en) | Slag granulation system and method of operation | |
| HK1187335A1 (en) | Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals 3-- | |
| HK1204343A1 (en) | Oxygen-enriched ti-6ai-4v alloy and process for manufacture ti-6ai-4v | |
| HK1204383A1 (en) | Method of and system for tracking gaming activity | |
| IL231505A0 (en) | Pharmaceutical composition and method of preparing same | |
| HK1188791A1 (en) | Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these | |
| EP2931196A4 (en) | System and method to locally deliver therapeutic agent to inner ear | |
| EP2774974A4 (en) | Brake fluid composition comprising tartaric acid and imidazole | |
| SG11201401289YA (en) | Medicinal agent responsive to metal salen complex compound, and system for controlling in vivo behavior of metal salen complex compound | |
| PL2869945T3 (en) | Continuously operating casting and rolling system | |
| EP2857028A4 (en) | Agent containing ascorbic acid derivative, and use for said agent | |
| EP2863981A4 (en) | Catheter system for delivery of solutions | |
| EP2781521A4 (en) | Novel spiroindoline compound, and medicinal agent comprising same | |
| AU2012901130A0 (en) | A composition and method for enhancing the permeability of a tissue of a subject to an active agent |